NCT00471575

Brief Summary

Non alcoholic fatty liver disease (NAFLD) is one of the main causes of development of chronic liver disease and cirrhosis. There are no published studies which have investigated the incidence of NAFLD in pregnant women or the correlation between the metabolic changes in pregnancy and this phenomenon. We aimed in our study to explore the incidence of NAFLD in pregnancy by ultrasonography (US) during the end of the pregnancy or immediately after birth (after 36 weeks) and to look for a correlation between fatty liver and demographic, clinical, nutritional and laboratory data during pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 10, 2007

Completed
22 days until next milestone

Study Start

First participant enrolled

June 1, 2007

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

May 15, 2007

Status Verified

April 1, 2007

First QC Date

May 9, 2007

Last Update Submit

May 13, 2007

Conditions

Fatty Liver

Keywords

fatty liverpregnancyultra soundPregnant women at the end of pregnancy or immediately after birth.controls-women with normal livercorrelation between ultrasonography and nutritional, obsthetric and laboratory data.

Interventions

ultra sound examinationPROCEDURE

Eligibility Criteria

Age18 Years+
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women during the end of the pregnancy or immediately after birth (after 36 weeks)

You may not qualify if:

  • Pregnant women before 36 weeks of pregnancy.
  • Known diabetes or treatment by drugs known to cause fatty liver.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh Medical Center

Ẕerifin, 70300, Israel

Location

MeSH Terms

Conditions

Fatty Liver

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System Diseases

Study Officials

  • efrat Broide, MD

    Ethic committee of Assaf Harofeh Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Efrat Broide, MD

CONTACT

972-8-9779722efibroide@yahoo.com

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
OTHER
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

May 9, 2007

First Posted

May 10, 2007

Study Start

June 1, 2007

Study Completion

December 1, 2007

Last Updated

May 15, 2007

Record last verified: 2007-04

Locations

IL(1)